JP2021530236A5 - - Google Patents
Info
- Publication number
- JP2021530236A5 JP2021530236A5 JP2021502833A JP2021502833A JP2021530236A5 JP 2021530236 A5 JP2021530236 A5 JP 2021530236A5 JP 2021502833 A JP2021502833 A JP 2021502833A JP 2021502833 A JP2021502833 A JP 2021502833A JP 2021530236 A5 JP2021530236 A5 JP 2021530236A5
- Authority
- JP
- Japan
- Prior art keywords
- heavy chain
- monoantibody
- sequence
- disease
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024020312A JP7737488B2 (ja) | 2018-07-20 | 2024-02-14 | Ｃｄ１９に結合する重鎖抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701281P | 2018-07-20 | 2018-07-20 | |
| US62/701,281 | 2018-07-20 | ||
| PCT/US2019/042633 WO2020018922A1 (en) | 2018-07-20 | 2019-07-19 | Heavy chain antibodies binding to cd19 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024020312A Division JP7737488B2 (ja) | 2018-07-20 | 2024-02-14 | Ｃｄ１９に結合する重鎖抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530236A JP2021530236A (ja) | 2021-11-11 |
| JP2021530236A5 true JP2021530236A5 (enExample) | 2022-07-26 |
| JP7439046B2 JP7439046B2 (ja) | 2024-02-27 |
Family
ID=67515196
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502833A Active JP7439046B2 (ja) | 2018-07-20 | 2019-07-19 | Ｃｄ１９に結合する重鎖抗体 |
| JP2024020312A Active JP7737488B2 (ja) | 2018-07-20 | 2024-02-14 | Ｃｄ１９に結合する重鎖抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024020312A Active JP7737488B2 (ja) | 2018-07-20 | 2024-02-14 | Ｃｄ１９に結合する重鎖抗体 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US12202898B2 (enExample) |
| EP (2) | EP3823990B1 (enExample) |
| JP (2) | JP7439046B2 (enExample) |
| KR (2) | KR102930803B1 (enExample) |
| CN (2) | CN112351997B (enExample) |
| AU (1) | AU2019305663B2 (enExample) |
| BR (1) | BR112020024074A2 (enExample) |
| CA (1) | CA3101069A1 (enExample) |
| DK (1) | DK3823990T3 (enExample) |
| ES (1) | ES3064933T3 (enExample) |
| FI (1) | FI3823990T3 (enExample) |
| HR (1) | HRP20260372T1 (enExample) |
| IL (2) | IL326259A (enExample) |
| LT (1) | LT3823990T (enExample) |
| MX (1) | MX2021000708A (enExample) |
| PL (1) | PL3823990T3 (enExample) |
| PT (1) | PT3823990T (enExample) |
| RS (1) | RS67881B1 (enExample) |
| SG (1) | SG11202011597RA (enExample) |
| SM (1) | SMT202600121T1 (enExample) |
| WO (1) | WO2020018922A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109641049B (zh) | 2016-06-21 | 2023-07-07 | 特尼奥生物股份有限公司 | Cd3结合抗体 |
| RU2762835C2 (ru) | 2016-08-24 | 2021-12-23 | Тенеобио, Инк. | Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи |
| MY200988A (en) | 2016-09-14 | 2024-01-27 | Teneobio Inc | CD3 Binding Antibodies |
| KR102745676B1 (ko) | 2016-12-21 | 2024-12-24 | 테네오바이오, 인코포레이티드 | 항-bcma 중쇄-단독 항체 |
| WO2018237006A1 (en) | 2017-06-20 | 2018-12-27 | Teneoone, Inc. | Anti-bcma heavy chain-only antibodies |
| IL312322B2 (en) | 2017-06-20 | 2026-05-01 | Teneobio Inc | Antibodies against BCMA containing only heavy chains |
| WO2019126756A1 (en) | 2017-12-22 | 2019-06-27 | Teneobio, Inc. | Heavy chain antibodies binding to cd22 |
| BR112020024074A2 (pt) | 2018-07-20 | 2021-02-17 | Teneobio, Inc. | anticorpos de cadeia pesada com ligação a cd19 |
| WO2020180882A1 (en) | 2019-03-05 | 2020-09-10 | Nkarta, Inc. | Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| CR20210500A (es) | 2019-04-05 | 2021-11-05 | Teneobio Inc | Anticuerpos de cadena pesada que se unen al psma |
| JP7665538B2 (ja) | 2019-06-14 | 2025-04-21 | テネオバイオ， インコーポレイテッド | Ｃｄ２２及びｃｄ３に結合する多重特異性重鎖抗体 |
| EP4592310A2 (en) * | 2020-03-16 | 2025-07-30 | Angeles Therapeutics, Inc. | Novel antigen binding domains and synthetic antigen receptors incorporating the same |
| WO2021222578A1 (en) | 2020-04-29 | 2021-11-04 | Teneobio, Inc. | Multispecific heavy chain antibodies with modified heavy chain constant regions |
| IL297601A (en) | 2020-04-29 | 2022-12-01 | Teneobio Inc | Multispecific heavy chain antibodies with modified heavy chain constant regions |
| EP4182351A4 (en) * | 2020-07-16 | 2024-12-11 | Legend Biotech Ireland Limited | CD19-BINDING MOLECULES AND THEIR USES |
| WO2022012680A1 (en) | 2020-07-16 | 2022-01-20 | Nanjing Legend Biotech Co., Ltd. | Cd20 binding molecules and uses thereof |
| WO2022060901A1 (en) | 2020-09-16 | 2022-03-24 | Amgen Inc. | Methods for administering therapeutic doses of bispecific t-cell engaging molecules for the treatment of cancer |
| KR20230166090A (ko) * | 2021-04-06 | 2023-12-06 | 테네오바이오, 인코포레이티드 | 항-cd19 항체 및 car-t 구조체 |
| WO2024243093A2 (en) * | 2023-05-19 | 2024-11-28 | The Regents Of The University Of California | Multispecific antibodies targeting cd3 and cd22 |
| EP4566619A1 (en) | 2023-12-08 | 2025-06-11 | AvenCell Therapeutics Inc. | Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed chimeric antigen receptor-mediated immune response in a mammal |
| WO2025222102A1 (en) * | 2024-04-19 | 2025-10-23 | TeneoTwo, Inc. | Therapeutic combinations of acalabrutinib and a multispecific antibody to treat b-cell malignancies |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| ATE255131T1 (de) | 1991-06-14 | 2003-12-15 | Genentech Inc | Humanisierter heregulin antikörper |
| US6066721A (en) | 1995-07-06 | 2000-05-23 | Stanford University | Method to produce novel polyketides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| ATE279947T1 (de) | 1996-03-18 | 2004-11-15 | Univ Texas | Immunglobulinähnliche domäne mit erhöhten halbwertszeiten |
| AU6232899A (en) | 1999-10-06 | 2001-05-10 | Campina Melkunie B.V. | Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| UA74798C2 (uk) | 1999-10-06 | 2006-02-15 | Байоджен Айдек Ма Інк. | Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами |
| CA2438682A1 (en) | 2001-02-20 | 2002-08-29 | Zymogenetics, Inc. | Antibodies that bind both bcma and taci |
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| EP1578447A4 (en) | 2002-10-31 | 2009-06-03 | Genentech Inc | METHOD AND COMPOSITIONS FOR INCREASING ANTIBODY PRODUCTION |
| CA2513113A1 (en) | 2003-01-23 | 2004-08-05 | Genentech, Inc. | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
| US20060008548A1 (en) | 2003-11-19 | 2006-01-12 | Invista North America S.A R.L. | Spinneret plate for producing a bulked continuous filament having a three-sided exterior cross-section and a convex six-sided central void |
| EP1978032A3 (en) | 2004-07-22 | 2009-02-18 | Erasmus University Medical Center Rotterdam | Binding molecules |
| CN101218351A (zh) * | 2005-02-15 | 2008-07-09 | 杜克大学 | 抗cd19抗体及其在肿瘤学中的应用 |
| HUE025945T2 (en) * | 2005-02-15 | 2016-07-28 | Univ Duke | Anti-CD19 antibodies and their applications in oncology |
| US20160355591A1 (en) | 2011-05-02 | 2016-12-08 | Immunomedics, Inc. | Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies |
| CA2688834C (en) | 2007-06-01 | 2020-01-07 | Ronald Buelow | Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| US20100122358A1 (en) | 2008-06-06 | 2010-05-13 | Crescendo Biologics Limited | H-Chain-only antibodies |
| EA024492B1 (ru) * | 2008-07-17 | 2016-09-30 | Новартис Аг | Антитела, специфически связывающиеся с baffr, и их применение |
| KR101589785B1 (ko) | 2009-03-10 | 2016-01-28 | 바이오젠 엠에이 인코포레이티드 | 항-ｂｃｍａ 항체 |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| US9345661B2 (en) | 2009-07-31 | 2016-05-24 | Genentech, Inc. | Subcutaneous anti-HER2 antibody formulations and uses thereof |
| TWI679212B (zh) | 2011-11-15 | 2019-12-11 | 美商安進股份有限公司 | 針對ｂｃｍａ之e3以及ｃｄ３的結合分子 |
| US9963513B2 (en) | 2013-02-05 | 2018-05-08 | Engmab Sàrl | Method for the selection of antibodies against BCMA |
| AP2017009823A0 (en) * | 2014-09-26 | 2017-03-31 | Macrogenics Inc | Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof |
| CN105384825B (zh) | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| US9914683B2 (en) * | 2016-05-26 | 2018-03-13 | X Development Llc | Fuel synthesis from an aqueous solution |
| CN109641049B (zh) | 2016-06-21 | 2023-07-07 | 特尼奥生物股份有限公司 | Cd3结合抗体 |
| RU2762835C2 (ru) | 2016-08-24 | 2021-12-23 | Тенеобио, Инк. | Трансгенные животные, отличные от человека, продуцирующие модифицированные антитела, содержащие только тяжелые цепи |
| MY200988A (en) | 2016-09-14 | 2024-01-27 | Teneobio Inc | CD3 Binding Antibodies |
| KR102745676B1 (ko) | 2016-12-21 | 2024-12-24 | 테네오바이오, 인코포레이티드 | 항-bcma 중쇄-단독 항체 |
| WO2018237006A1 (en) | 2017-06-20 | 2018-12-27 | Teneoone, Inc. | Anti-bcma heavy chain-only antibodies |
| IL312322B2 (en) | 2017-06-20 | 2026-05-01 | Teneobio Inc | Antibodies against BCMA containing only heavy chains |
| KR102757010B1 (ko) | 2017-06-30 | 2025-01-23 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 인간 도메인을 갖는 항-b 세포 성숙화 항원 키메라성 항원 수용체 |
| BR112020013086A2 (pt) | 2017-12-27 | 2020-12-08 | Teneobio, Inc. | Anticorpos específicos de heterodímero de cd3-delta/épsilon |
| CA3101340A1 (en) | 2018-05-24 | 2019-11-28 | Ayala Pharmaceuticals Inc. | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and immunotherapeutics and methods of use thereof |
| BR112020024074A2 (pt) | 2018-07-20 | 2021-02-17 | Teneobio, Inc. | anticorpos de cadeia pesada com ligação a cd19 |
| JP7665538B2 (ja) | 2019-06-14 | 2025-04-21 | テネオバイオ， インコーポレイテッド | Ｃｄ２２及びｃｄ３に結合する多重特異性重鎖抗体 |
| IL297601A (en) | 2020-04-29 | 2022-12-01 | Teneobio Inc | Multispecific heavy chain antibodies with modified heavy chain constant regions |
-
2019
- 2019-07-19 BR BR112020024074-5A patent/BR112020024074A2/pt unknown
- 2019-07-19 FI FIEP19749123.6T patent/FI3823990T3/fi active
- 2019-07-19 KR KR1020207034987A patent/KR102930803B1/ko active Active
- 2019-07-19 PL PL19749123.6T patent/PL3823990T3/pl unknown
- 2019-07-19 CN CN201980035712.8A patent/CN112351997B/zh active Active
- 2019-07-19 PT PT197491236T patent/PT3823990T/pt unknown
- 2019-07-19 CN CN202310539593.8A patent/CN116769032A/zh active Pending
- 2019-07-19 MX MX2021000708A patent/MX2021000708A/es unknown
- 2019-07-19 IL IL326259A patent/IL326259A/en unknown
- 2019-07-19 SG SG11202011597RA patent/SG11202011597RA/en unknown
- 2019-07-19 KR KR1020267005215A patent/KR20260036383A/ko active Pending
- 2019-07-19 SM SM20260121T patent/SMT202600121T1/it unknown
- 2019-07-19 EP EP19749123.6A patent/EP3823990B1/en active Active
- 2019-07-19 US US17/260,213 patent/US12202898B2/en active Active
- 2019-07-19 RS RS20260319A patent/RS67881B1/sr unknown
- 2019-07-19 JP JP2021502833A patent/JP7439046B2/ja active Active
- 2019-07-19 CA CA3101069A patent/CA3101069A1/en active Pending
- 2019-07-19 LT LTEPPCT/US2019/042633T patent/LT3823990T/lt unknown
- 2019-07-19 WO PCT/US2019/042633 patent/WO2020018922A1/en not_active Ceased
- 2019-07-19 DK DK19749123.6T patent/DK3823990T3/da active
- 2019-07-19 ES ES19749123T patent/ES3064933T3/es active Active
- 2019-07-19 AU AU2019305663A patent/AU2019305663B2/en active Active
- 2019-07-19 HR HRP20260372TT patent/HRP20260372T1/hr unknown
- 2019-07-19 EP EP25219867.6A patent/EP4714502A2/en active Pending
-
2020
- 2020-11-26 IL IL279010A patent/IL279010B1/en unknown
-
2024
- 2024-02-14 JP JP2024020312A patent/JP7737488B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537931A5 (enExample) | ||
| JP2022505445A5 (enExample) | ||
| JP2024507540A5 (enExample) | ||
| JP2023526774A5 (enExample) | ||
| US11987635B2 (en) | Anti-4-1BB antibodies and methods of making and using thereof | |
| AU2014228962B2 (en) | Multimerization technologies | |
| JP2022526595A5 (enExample) | ||
| RU2004121673A (ru) | Человеческие полипептиды, вызывающие или опосредующие лизис клеток, включая клетки лимфоидных опухолей | |
| JP2024062992A5 (enExample) | ||
| JP2023517753A5 (enExample) | ||
| JP2024508808A5 (enExample) | ||
| JP2024514107A5 (enExample) | ||
| RU99101121A (ru) | Полипептиды, способные к образованию антигенсвязывающих структур со специфичностью к резус-d-антигенам, днк, кодирующая их, способы их получения и применение | |
| JP2024516098A5 (enExample) | ||
| WO2020172641A1 (en) | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| JP2026510999A (ja) | Ｃｄ１９／ｃｄ３８多重特異性抗体 | |
| JP2022516301A (ja) | Ｃｄ１３７アゴニスト性抗体とその使用 | |
| CN104105706A (zh) | 用于治疗疾病的抗人sema4A抗体 | |
| JP2025530888A5 (enExample) | ||
| JP2024508360A (ja) | 抗ｃ４ｄキメラ抗原受容体調節性ｔ細胞およびその使用 | |
| JPH05503687A (ja) | 自己免疫疾患の治療 | |
| CN114685659B (zh) | Cd22特异性人源化抗体及利用其的嵌合抗原受体 | |
| WO2023045370A1 (zh) | 靶向tigit的单克隆抗体 | |
| CN116023496A (zh) | 一种制备通用型car-t细胞的方法及其应用 | |
| IL295993A (en) | Anti-cd19 antibodies and methods of using and making thereof |